Corcept Therapeutics Incorporated (CORT) Q4 2020 Earnings Call Transcript
CORT earnings call for the period ending December 31, 2020.
A pharmaceutical company which is engaged in the development of drugs for the treatment of severe psychiatric and metabolic diseases.
CORT earnings call for the period ending December 31, 2020.
A patent decision on its cortisol therapy Korlym is expected to be rendered next month.
These two biotechs have the potential to become giants within their domains.
CORT earnings call for the period ending July 31, 2020.
This biotech company has seen huge growth over the past five years.
CORT earnings call for the period ending March 31, 2020.
CORT earnings call for the period ending December 31, 2019.
The company's fight to keep generic competition at bay took a turn for the worse.
CORT earnings call for the period ending September 30, 2019.
CORT earnings call for the period ending June 30, 2019.